相似文献
1
p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy.
World J Gastroenterol. 2005 Sep 28;11(36):5696-700. doi: 10.3748/wjg.v11.i36.5696.
2
CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers.
Clin Cancer Res. 2000 Dec;6(12):4859-65.
3
Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer.
Br J Surg. 2002 May;89(5):597-603. doi: 10.1046/j.1365-2168.2002.02057.x.
4
Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
Br J Cancer. 2001 Aug 3;85(3):412-21. doi: 10.1054/bjoc.2001.1934.
5
Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
J Surg Oncol. 2005 Jul 1;91(1):84-9. doi: 10.1002/jso.20279.
6
Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol. 2018 Feb;25(2):449-455. doi: 10.1245/s10434-017-6271-y. Epub 2017 Nov 29.
7
Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
Anticancer Res. 1999 Nov-Dec;19(6C):5515-21.
8
Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy.
Dis Esophagus. 2004;17(4):315-21. doi: 10.1111/j.1442-2050.2004.00433.x.
9
Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Anticancer Res. 2005 Jul-Aug;25(4):2749-55.
10
Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
Jpn J Clin Oncol. 2007 Sep;37(9):652-7. doi: 10.1093/jjco/hym089.
引用本文的文献
1
Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: A meta-analysis.
PLoS One. 2022 Aug 5;17(8):e0271242. doi: 10.1371/journal.pone.0271242. eCollection 2022.
2
Metallothionein - immunohistochemical cancer biomarker: a meta-analysis.
PLoS One. 2014 Jan 8;9(1):e85346. doi: 10.1371/journal.pone.0085346. eCollection 2014.
3
Serum metallothioneins in childhood tumours-a potential prognostic marker.
Int J Mol Sci. 2013 Jun 6;14(6):12170-85. doi: 10.3390/ijms140612170.
4
Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy.
Surg Today. 2014 Mar;44(3):421-8. doi: 10.1007/s00595-013-0580-y. Epub 2013 Apr 19.
5
Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients.
Br J Cancer. 2006 Mar 27;94(6):835-41. doi: 10.1038/sj.bjc.6603028.
本文引用的文献
1
[Docetaxel and squamous cell carcinoma of the head and neck].
Bull Cancer. 2004 Feb;91(2):167-71.
2
Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus.
Dis Esophagus. 2003;16(2):112-8. doi: 10.1046/j.1442-2050.2003.00309.x.
3
Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis.
Int J Cancer. 2003 Feb 10;103(4):445-54. doi: 10.1002/ijc.10850.
4
Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas.
Int J Cancer. 2001 Sep 1;93(5):662-6. doi: 10.1002/ijc.1379.
5
CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers.
Clin Cancer Res. 2000 Dec;6(12):4859-65.
6
Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years.
Ann Surg. 2000 Aug;232(2):225-32. doi: 10.1097/00000658-200008000-00013.
7
Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: goal of cure with organ preservation.
Radiother Oncol. 2000 Feb;54(2):129-34. doi: 10.1016/s0167-8140(99)00174-7.
8
Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.
J Clin Oncol. 1999 Sep;17(9):2915-21. doi: 10.1200/JCO.1999.17.9.2915.
9
BCL-2 family members and the mitochondria in apoptosis.
Genes Dev. 1999 Aug 1;13(15):1899-911. doi: 10.1101/gad.13.15.1899.
10
Metallothionein expression correlates with the pathological response of patients with esophageal cancer undergoing preoperative chemoradiation therapy.
Oncology. 1999;56(4):332-7. doi: 10.1159/000011988.
Zotero 插件